Share This

Related Topics News - Drugs

     
 Detail   |   Print    Next page > 
     
《盈喜》精優藥業預告虧轉盈 全年溢利最少2.15億元
2025-06-23T  
《大行》大和升中生製藥目標價至5.6元 重申「買入」
2025-06-23T  
石藥美洛昔康注射液獲內地藥品註冊批件
2025-06-23T  
《大行》美銀升中生製藥目標至5.9元 重申買入
2025-06-20T  
《新股》泰德醫藥今起招股入場費3,091元 引石藥為基投
2025-06-20T  
《瑞銀窩輪》大市曾挫超過500點資金一面倒流入恆指牛證 兩手部署恆指牛證(59346)、恆指熊證(64039)
2025-06-19T  
《大行》中銀國際列出「南向資金」今年以來活躍交易股份名單(表)
2025-06-19T  
中國生物製藥羅伐昔替尼臨床前及臨床數據在EHA公布
2025-06-18T  
中國生物製藥TDI01混懸液新適應症被納入突破性治療藥物程序
2025-06-16T  
《大行》野村升石藥集團目標價至10.22元 評級「買入」
2025-06-16T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.